Infection Related to Short-term Central Venous Catheters

Status Recruiting

Clinical Trial Summary

This study aims to evaluate the incidence of infection of short-term central venous catheters by comparing different cannulation techniques (by anatomical references and under ultrasound control) and according to the experience of the operator in patients undergoing elective surgery. A prospective observational study will be carried out in which all scheduled surgery patients who have a central venous line inserted for 12 months will be included. Those under 18 years of age, patients with catheters lasting more than 14 days and those who do not sign the informed consent will be excluded from this study. A chest X-ray will be performed on all patients in order to diagnose possible complications associated with the technique and, only in case of suspected infection, culture of the catheter tip and blood cultures of blood obtained from the catheter and peripheral blood will be requested.

Clinical Trial Description

A prospective observational study will be carried out. The maximum time between the intervention and the final evaluation will be 21 days, since the study evaluates the infection related to short-term catheters and its probable improvement after the removal of the device. All patients undergoing elective surgery who have a central venous line inserted for 12 months will be included in the study. Those under 18 years of age, patients with catheters lasting more than 14 days and those who do not sign the informed consent will be excluded. A follow-up of the central venous catheters that are inserted in those patients scheduled for surgery who have an indication for it will be carried out. The criteria for choosing the access route will be carried out according to the usual clinical practice of the responsible anesthesiologist. The asepsis measures that will be carried out both in the insertion and in the maintenance of the catheter will be those used on a regular basis, which follow the recommendations of the guidelines for the prevention of infections related to intravascular catheters of the American Center for Control and Prevention. of Diseases. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05495646
Study type	Observational
Source	Dr. Negrin University Hospital
Contact	Yurena Domínguez, MD
Phone	+34928450370
Email	yurena.dd@gmail.com
Status	Recruiting
Phase
Start date	August 8, 2022
Completion date	March 30, 2024

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT04787926` - DuraLock-C Catheter Lock Solution
Active, not recruiting	`NCT02515201` - Heparin Versus Taurolidine to Bloodstream Infection Prevention Related in Central Venous Catheter in Children	Phase 4
Recruiting	`NCT04140916` - Comparison of Two Peripheral Inserted Intravenous Catheters	N/A
Not yet recruiting	`NCT06019897` - Impact of Tubing Colonization on the Incidence of Central Venous Catheter Infection
Completed	`NCT02970409` - Heparin Versus Saline in Peripheral Venous Catheter	N/A
Completed	`NCT03101371` - Reducing Urinary Tract Infection Rates Using a Controlled Aseptic Protocol for Catheter Insertion	Phase 2
Completed	`NCT04821193` - Comparison of the Effects of 5%NaHCO3, 2%CHG and 70%Alcohol in the Prevention of Infections Related to Catheter	N/A
Completed	`NCT04155723` - Impact of a Task Delegation to ICU Nurses for Midlines' Placement
Completed	`NCT02577718` - Safety and Effectiveness of Novel Nitroglycerin Based Catheter Lock Solution	Phase 1/Phase 2
Completed	`NCT02279121` - ATAPAC Study (TauroLock Activity in Adult Cancer Patients)	N/A
Completed	`NCT00965198` - Comparison of Infection Rates Among Patients Using Two Catheter Access Devices	N/A
Recruiting	`NCT05741866` - Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs)	N/A
Recruiting	`NCT04825314` - Noble Meta Alloy Coated Catheters in Patients With Long Term Catheterization	N/A
Active, not recruiting	`NCT03945045` - A Study of the IJV or the SCV Approach for Ultrasound-guided Implantation of TIVAD	N/A
Active, not recruiting	`NCT01592032` - Concentration of Antimicrobials in Catheter-lock Solutions	Phase 4
Terminated	`NCT04906512` - Comparing CHG I.V. Securement Dressing With Transparent Dressing for Evaluation of Antimicrobial Efficacy	N/A
Withdrawn	`NCT02899780` - Treatment of Infected Dialysis Catheters With Fiber Optic Ultraviolet Light	N/A
Recruiting	`NCT05995080` - The Effectiveness of Chlorhexidine Gluconate on Prevention of Catheter-Related Bloodstream Infections	N/A
Completed	`NCT04794231` - Comparison of Chlorhexidine Impregnated Dressing and Standard Dressing	N/A
Terminated	`NCT03447639` - Betadine Bladder Irrigations vs. Standard of Care Prior to Indwelling Catheter Removal	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.